Hunan Er-Kang Pharmaceutical Co., Ltd Sustainability Profile
Hunan Er-Kang Pharmaceutical Co., Ltd., commonly referred to as Er-Kang, is a prominent player in the pharmaceutical industry, headquartered in Changsha, Hunan, China. Established in 1998, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong focus on research and innovation, Er-Kang offers a diverse range of core products, including herbal extracts and prescription medications, which are distinguished by their efficacy and adherence to stringent quality standards. The company has established a solid market position, recognised for its commitment to advancing healthcare solutions both domestically and internationally. Through continuous improvement and strategic partnerships, Hunan Er-Kang Pharmaceutical Co., Ltd. remains dedicated to enhancing the well-being of patients worldwide.
DitchCarbon Score
How does Hunan Er-Kang Pharmaceutical Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hunan Er-Kang Pharmaceutical Co., Ltd's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hunan Er-Kang Pharmaceutical Co., Ltd's reported carbon emissions
Hunan Er-Kang Pharmaceutical Co., Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions or reduction initiatives reported, it is unclear how Hunan Er-Kang Pharmaceutical is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The lack of data may suggest an opportunity for the company to enhance its sustainability practices and align with industry standards for emissions reporting and reduction commitments.
How Carbon Intensive is Hunan Er-Kang Pharmaceutical Co., Ltd's Industry?
How Carbon Intensive is Hunan Er-Kang Pharmaceutical Co., Ltd's Location?
Hunan Er-Kang Pharmaceutical Co., Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hunan Er-Kang Pharmaceutical Co., Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
